When you absolutely have to recruit patients on time.

Home 5 Company News 5 A Phase II Non-Small Cell Lung Cancer is starting at Accell Clinical Research

A Phase II Non-Small Cell Lung Cancer is starting at Accell Clinical Research

We have obtained regulatory approval for a Phase II study in patients with NSCLC. The clinical study will be conducted at 6 sites in Russia and will enroll 20 patients.

Company News

This Is Your Team. We Make Clinical Trials Happen.


our SERVICES MENU


From clinical research associates to hands-on founders, we fiercely pursue our strategic goal: deliver on schedule. We think of ourselves as your development partner, not a vendor.